Cardiac sarcoidosis with complete metabolic response and resolution of left ventricular dysfunction complicated by subsequent VT storm.
PET
Sarcoid heart disease
molecular imaging
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
27
09
2018
accepted:
04
10
2018
pubmed:
1
11
2018
medline:
23
6
2021
entrez:
1
11
2018
Statut:
ppublish
Résumé
Sarcoidosis is a multisystem granulomatous disease of unknown aetiology that involves primarily the lungs and lymph nodes. Cardiac involvement is less common but associated with a poorer prognosis. With contemporary diagnostic modalities such as cardiac magnetic resonance and fluorine-18-fluoro-deoxy-glucose positron emission tomography computed tomography, cardiac involvement in sarcoidosis is increasingly diagnosed with appropriate therapy improving outcomes. Although steroid therapy may be protective or therapeutic in preventing left ventricular scarring and preserving LV function, it may not be as effective in the late stages of disease. (Chiu et al in Am J Cardiol 95:143-146, 2005) We present a case of cardiac sarcoidosis with significantly impaired ejection fraction that was diagnosed late in the course of disease with complete metabolic response to therapy and an improvement of LV function, but with a subsequent complication of ventricular tachycardia storm.
Identifiants
pubmed: 30377998
doi: 10.1007/s12350-018-01486-x
pii: 10.1007/s12350-018-01486-x
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
322-325Références
Am J Cardiol. 2005 Jan 1;95(1):143-6
pubmed: 15619415
Heart Rhythm. 2014 Jul;11(7):1305-23
pubmed: 24819193
Circ Arrhythm Electrophysiol. 2015 Feb;8(1):87-93
pubmed: 25527825
N Engl J Med. 1998 Jul 16;339(3):173-81
pubmed: 9664095